RE: The word is spreading . . . .22 Sep 2023 01:51
Chilltime 6068 on PoG made me chuckle :-
""Institutions - That news, the way it was written, then the live meet with broker analyst questions was a complete step change to the past. All too often as private high stakes investors we anticipate x,y or z will excite big industry and surely become a blockbuster. The beauty of this sector is if you find the magic mix, to beat the standard of care by the required margin, it’s not a case of IF but when. The institutions buy in, the dabbling trader/holders shares are gobbled up.
Scancell has been largely ignored other than by Redmile and Vulpes.
The analyst questions, summed up that point :-
“Do you inject into THE tumour?”
The answer should have been -“No you blithering idiot it’s a shot in the arm vaccine”
Then - Is the injection method approved🤦♂️🤦♂️🤦♂️?
Answer - “Yes you complete t*t, do you actually read the news, or have the slightest clue about Scancell, it’s easier to deliver than a typical injection, with no needle fear involved”
The analysts will be excited as will Bristol Myers.""
Thanks Chill - please excuse minor edits.